Sleeve gastrectomy versus tirzepatide to improve survival among patients with stage 5 CKD: A Markov decision analysis
- 15 May 2026
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 261, 117027
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or ObesityJAMA Internal Medicine, 2024
- Bariatric surgery and the diseased kidney: a 5-year assessment of safety and postoperative renal outcomesSurgical Endoscopy, 2024
- Sleeve Gastrectomy Reduces the Need for Liver Transplantation in Patients with Obesity and Non-Alcoholic Steatohepatitis: a Predictive ModelObesity Surgery, 2024
- SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world studyDiabetologia, 2023
- Improvement of Renal Function After Bariatric Surgery: a Systematic Review and Meta-analysisObesity Surgery, 2021
- Weight Regain and Insufficient Weight Loss After Bariatric Surgery: Definitions, Prevalence, Mechanisms, Predictors, Prevention and Management Strategies, and Knowledge Gaps—a Scoping ReviewObesity Surgery, 2021
- Bariatric Surgery and Long-term Survival in Patients With Obesity and End-stage Kidney DiseaseJAMA Surgery, 2020
- Safety and efficacy of the sleeve gastrectomy as a strategy towards kidney transplantationSurgical Endoscopy, 2019
- Cardiovascular and Renal Effects of Weight Reduction in Obesity and the Metabolic SyndromeCurrent Hypertension Reports, 2015
- Re-examining the BMI Threshold for Bariatric Surgery in the USAJournal of Gastrointestinal Surgery, 2014